Skip to main content
. 2019 Feb 26;141(3):164–175. doi: 10.1159/000495206

Fig. 3.

Fig. 3

Forest plot of the OS benefit of alloSCT in intermediate-risk AML/CR1. a Forest plot of the overall OS benefit and the subgroup OS benefit based on FLT3-ITD status. b Forest plot of the subgroup OS benefit based on donor category of alloSCT.